CHU de Nancy

Vandœuvre-lès-Nancy 54511

0 studies enrolling now · 4 studies all time

What they study most

Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients., Graft-versus-host Disease (GVHD), Hepatitis C, Chronic, Non-Hodgkin's Lymphoma

Studies at this site

• GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease — Completed
• Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication — Completed